Gene Expression and Epigenetic Analyses of Human Myocytes from Different Muscles
Demographics (2)
- AGE - Subject age at enrollment or collection (phv00493833.v2.p1)
- SEX - Biological sex (phv00493828.v2.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for facioscapulohumeral muscular dystrophy (FSHD) (phv00493832.v2.p1)
Other (23)
- 4QA_ALLELE_1 - 4qA allele classification for allele 1 (phv00493838.v2.p1)
- 4QA_ALLELE_2 - 4qA allele classification for allele 2 (phv00493839.v2.p1)
- 4QA_UNITS - Number of preserved 4qA units (phv00493837.v2.p1)
- ANALYTE_TYPE - Analyte Type (phv00493843.v3.p1)
- BIOPSY_SIDE - The side of the body from which the biopsy was collected (phv00493834.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00493842.v3.p1)
- CONSENT - Consent group as determined by DAC (phv00493827.v2.p1)
- DIFFERENTIATION_DAY - Number of days following addition of differentiation media (phv00493846.v3.p1)
- EB_ALLELE_1 - Southern band size from EcoR1/Bln1-digested DNA with p13E11 probe for allele 1 (phv00493835.v2.p1)
- EB_ALLELE_2 - Southern band size from EcoR1/Bln1-digested DNA with p13E11 probe for allele 2 (phv00493836.v2.p1)
- FSHD_STATUS - FSHD diagnosis (phv00493845.v3.p1)
- GEO_ACCESSION - GEO accession ID (phv00494227.v1.p1)
- IMMORTALIZED - Immortalized from primary lines (phv00496032.v2.p1)
- IS_TUMOR - Tumor status (phv00493844.v3.p1)
- MODIFIED - Genetically modified by CRISPR-Cas9 (phv00496033.v2.p1)
- SAMPLE_ID - Sample ID (phv00493841.v3.p1)
- SAMPLE_ID - Sample ID (phv00493830.v3.p1)
- SAMPLE_ID - Sample ID (phv00494226.v1.p1)
- SMCHD1_MUTATION - SMCHD1 mutation (phv00493840.v2.p1)
- SUBJECT_ID - Subject ID (phv00493831.v2.p1)
- SUBJECT_ID - Subject ID (phv00493826.v2.p1)
- SUBJECT_ID - Subject ID (phv00493829.v3.p1)
- TREATMENT - 5AzaC treated samples (phv00496034.v2.p1)